The Temporal Course of Adenovirus-Mediated Gene Transfer in the Rat Larynx

Abstract

OBJECTIVE: Polypeptide growth factors have important influences on wound-healing and scar tissue formation. Specific growth factors or their inhibitors may potentially decrease scar tissue formation and prevent subglottic stenosis. Gene transfer using recombinant adenovirus may be an ideal method to mediate endogenous production of growth factors to inhibit fibrosis.

STUDY DESIGN: The study incorporated adenovirus-mediated transduction of normal and stenotic rat larynges and histologic analysis of the sequential expression of a β-galactosidase marker gene over time.

SETTING: The study was conducted at the animal care facility of an academic children's hospital.

RESULTS: We report successful transduction in normal and injured rat larynx with peak expression of β-galactosidase at 2 days after transduction and almost complete disappearance by 7 days. There appeared to be an early inflammatory response to the viral injection, but at 7 and 14 days after injection (transduction) the uninjured rat larynges resumed a normal histologic appearance. All distant sites stained negative for β-galactosidase.

CONCLUSION: Recombinant adenovirus-mediated gene transfer is feasible in the rat larynx with transient duration and limited toxicity.

SIGNIFICANCE: Adenovirus-mediated gene transfer has the potential to deliver growth factors that modulate wound healing and inflammation in the larynx by inhibiting fibrosis.

Get full access to this article

View all access options for this article.

References

Jain

Vectors for gene therapy. In: Textbook of gene therapy, ed 1. Seattle, WA: Hogrefe and Huber Publishers; 1998. Chapter 4.

Setoguchi

Jaffe

Danel

, et al. Ex vivo and in vivo gene transfer to skin using replication-deficient recombinant vectors. Soc Invest Dermatol 1994;102:415–21.

Goldman

Yang

Wilson

Gene therapy in a zenograft model of cystic fibrosis lung corrects chloride transport more effectively than sodium defect. Nat Genet 1995;9:126–31.

Dupuit

Zahm

J-M

Pierrot

, et al. Regenerating cells in human airway surface epithelium represent preferential targets for recombinant adenovirus. Hum Gene Ther 1995; 6;1185–93.

Jiang

Akita

Collegel

, et al. Increased contact time improves adenovirus-mediated CFTR gene transfer to nasal epithelium of CF mice. Hum Gene Ther 1997;8:671–80.

Parkin

Stevens

Jung

Acquired and congenital subglottic stenosis in the infant. Ann Otol Rhinol Laryngol 1976;85:573–81.

Shah

Foreman

Ferguson

MWJ

Neutralisation of TGF-β₁ and TGF-β₂ or exogenous addition of TGF-β₃ to cutaneous rat wounds reduces scarring. J Cell Sci 1995;108:985–1002.

Border

Noble

Yamamoto

, et al. Natural inhibitor of transforming growth factor-B protects against scarring in experimental kidney disease. Nature 1992;9360:361–4.

Hom

Growth factors and wound-healing in otolaryngology. Otolaryngol Head Neck Surg 1994;110:560–4.

10.

11.

Graham

A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973;52:456–67.

12.

Wang

Finer

Second-generation adenovirus vectors. Nat Med 1996;2:714–6.

13.

Kaplan

Smith

Transient immunosuppression with deoxyspergualin improves longevity of transgene expression and ability to re-administer adenoviral vector to the mouse lung. Hum Gene Ther 1997;8:1095–104.

14.

Worgall

Leoplad

Wolff

, et al. Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract. Hum Gene Ther 1997;8:1675–84.